This document has not been cited yet.

1. ABDA (2016): Die Apotheke Zahlen Daten Fakten 2016, http://www.abda.de/service/ publikationen/ZDF [accessed 29 June 2016].
   Paper not yet in RePEc: Add citation now
   

2. Augurzky, B., S. Goehlmann, S. Gress, and J. Wasem (2009): Eects of the German reference drug program on ex-factory prices of prescription drugs: A panel data approach, Health Economics, 18(4), 421436.

3. Baicker, K., and D. Goldman (2011): Patient cost-sharing and healthcare spending growth, Journal of Economic Perspectives, 25(2), 4768.

4. Bajari, B. P., J. C. Fruehwirth, K. I. Kim, and C. Timmins (2012): A rational expectations approach to hedonic price regressions with time-varying unobserved product attributes: The price of pollution, American Economic Review, 102(5), 18981926.

5. Berndt, E. R., A. Bir, S. H. Busch, R. G. Frank, and S. L. T. Normand (2002): The medical treatment of depression, 1991-1996: Productive ineciency, expected outcome variations, and price indexes, Journal of Health Economics, 21(3), 373396.
   Paper not yet in RePEc: Add citation now
   
6. Berndt, E. R., and J. P. Newhouse (2012): Pricing and reimbursement in U.S. pharmaceutical markets, in The Oxford Handbook on the Economics of the Biopharmaceutical Industr y, ed. by P. M. Danzon, and S. N. Nicholson, chap. 8, pp. 201265. New York: Oxford University Press.
   Paper not yet in RePEc: Add citation now
   
7. Berndt, E. R., R. S. Pindyck, and P. Azoulay (2003): Consumption externalities and diusion in pharmaceutical markets: Antiulcer drugs, The Journal of Industrial Economics, 51(2), 243270.
   Paper not yet in RePEc: Add citation now
   

8. Berndt, E. R., T. McGuire, and J. P. Newhouse (2011): A primer on the economics of prescription pharmaceutical pricing in health insurance markets, Forum for Health Economics & Policy, 14(2), 130.

9. Bhattacharya, J., and W. Vogt (2003): A simple model of pharmaceutical price dynamics, Journal of Law and Economics, 46(2), 599626.

10. Blankart, C. R., and T. Stargardt (2016): Preferred supplier contracts in post-patent prescription drug markets, Health Care Management Science, pp. 114.

11. Boes, S., and M. Gerfin (2015): Does full insurance increase the demand for health care?, Health Economics, online rst.

12. Brekke, K. R., A. L. Grasdal, and T. H. Holmas (2009): Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?, European Economic Review, 53(2), 170185.

13. Brekke, K. R., T. H. Holmas, and O. R. Straume (2011): Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment, Journal of Public Economics, 95(7), 624638.

14. Cabrales, A., and S. Jimenez-Martin (2013): The determinants of pricing in pharmaceuticals: Are US prices really so high?, Health Economics, 22, 13771397.

15. Dalton, C. M. (2014): Estimating demand elasticities using nonlinear pricing, International Journal of Industrial Organization, 37, 178191.

16. Danzon, P. M., and J. D. Ketcham (2004): Reference pricing of pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand, Forum for Health Economics & Policy, 7(1), 147.

17. Danzon, P. M., and L. W. Chao (2000): Cross-national price dierences for pharmaceuticals: How large, and why?, Journal of Health Economics, 19(2), 159196.

18. DIMDI (2011): Deutsches Institut fuer Medizinische Dokumentation und Information: Arzneimittel Festbetraege, http://www.dimdi.de.
    Paper not yet in RePEc: Add citation now
    

19. Duggan, M. G., and F. S. Morton (2011): The medium-term impact of Medicare Part D on pharmaceutical prices, American Economic Review: Papers & Proceedings, 101(3), 387392.

20. Duso, T., A. Herr, and M. Suppliet (2014): The welfare impact of parallel imports: A structural approach applied to the German market for oral anti-diabetics, Health Economics, 23(9), 10361057.

21. Einav, L., A. Finkelstein, and P. Schrimpf (2015): The response of drug expenditures to non-linear contract design: Evidence from Medicare Part D, Quarterly Journal of Economics, 130(2), 841899.

22. Epstein, A. J., and J. D. Ketcham (2014): Information technology and agency in physicians' prescribing decisions, RAND Journal of Economics, 45(2), 422448.

23. FASHI (2011): Federal Association of Statutory Health Insurance Funds: List of co-payment exempt products, https://www.gkv-spitzenverband.de/krankenversicherung/arzneimittel/ zuzahlungsbefreiung/zuzahlungsbefreiung.jsp.
    Paper not yet in RePEc: Add citation now
    

24. Ferrara, I., and P. Missios (2012): Pricing of drugs with heterogeneous health insurance coverage, Journal of Health Economics, 31, 440456.

25. Ferrara, I., and Y. Kong (2008): Can health insurance coverage explain the generic competition paradox?, Economics Letters, 101(1), 4852.

26. Frank, R. G., and D. S. Salkever (1997): Generic entry and the pricing of pharmaceuticals, Journal of Economics & Management Strategy, 6(1), 7590.

27. Frank, R. G., and J. P. Newhouse (2008): Should drug prices be negotiated under part D of Medicare? And if so, how?, Health Aairs, 27(1), 3343.
    Paper not yet in RePEc: Add citation now
    

28. Ganslandt, M., and K. E. Maskus (2004): Parallel imports and the pricing of pharmaceutical products: Evidence from the European Union, Journal of Health Economics, 23(5), 10351057.

29. Gerfin, M., B. Kaiser, and C. Schmid (2015): Healthcare demand in the presence of discrete price changes, Health Economics, 24, 11641177.

30. Grabowski, H., and M. Kyle (2007): Generic competition and market exclusivity periods in pharmaceuticals, Managerial and Decision Economics, 28, 491502.

31. Gruber, J. (2006): The role of consumer copayments for health care: Lessons from the RAND Health Insurance Experiment and beyond, http://kaiserfamilyfoundation.files. wordpress.com/2013/01/7566.pdf.
    Paper not yet in RePEc: Add citation now
    

32. Hackmann, M. B., J. T. Kolstad, and A. E. Kowalski (2015): Adverse selection and an individual mandate: When theory meets practice, American Economic Review, 105(3), 1030 1066.

33. Hansen, L. P. (1982): Large sample properties of generalized method of moments estimators, Econometrica, 50(4), 10291054.

34. Hellerstein, J. K. (1998): The importance of the physician in the generic versus trade-name prescription decision, The RAND Journal of Economics, pp. 108136.

35. Herr, A., T. Stuehmeier, and T. Wenzel (2015): Reference pricing and cost-sharing: Theory and evidence on German o-patent drugs, mimeo.

36. Hoadley, J., L. Summer, E. Hargrave, J. Cubanski, and T. Neuman (2012): Analysis of Medicare prescription drug plans in 2012 and key trends since 2006, http://www.kff.org/ medicare/8357.cfm.
    Paper not yet in RePEc: Add citation now
    

37. Huskamp, H. A., R. G. Frank, K. A. McGuigan, and Y. Zhang (2005): The impact of a three-tier formulary on demand response for prescription drugs, Journal of Economics and Management Strategy, 14(3), 729753.

38. Iizuka, T., and G. Z. Jin (2007): Direct to consumer advertising and prescription choice, Journal of Industrial Economics, 55(4), 771771.

39. Kaiser, U., S. J. Mendez, T. Rønde, and H. Ullrich (2014): Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark, Journal of Health Economics, 36(1), 174187.

40. Lakdawalla, D., and N. Sood (2013): Health insurance as a two-part pricing contract, Journal of Public Economics, 102, 112.

41. Lakdawalla, D., N. Sood, and Q. Gu (2013): Pharmaceutical advertising and Medicare Part D, Journal of Health Economics, 32(6), 13561367.

42. Landsman, P., W. Yu, X.Liu, S. M. Teutsch, and M. L. Berger (2005): Impact of 3-tier pharmacy benet design and increased consumer cost-sharing on drug utilization, American Journal of Managed Care, 11, 621628.
    Paper not yet in RePEc: Add citation now
    
43. McGuire, T. G. (2000): Physician agency, in Handbook of Health Economics, ed. by A. J. Culyer, and J. P. Newhouse, chap. 9, pp. 461536. Elsevier.
    Paper not yet in RePEc: Add citation now
    

44. Nabin, M. H., V. Mohan, A. Nicholas, and P. M. Sgro (2012): Therapeutic equivalence and the generic competition paradox, The BE Journal of Economic Analysis & Policy, 12(1), 124.

45. Pakes, A. (2003): A reconsideration of hedonic price indexes with an application to PC's, The American Economic Review, 93(5), 15781596.

46. Pavcnik, N. (2002): Do pharmaceutical prices respond to potential patient out-of-pocket expenses ?, The RAND Journal of Economics, 33(3), 469487.

47. Regan, T. (2008): Generic entry, price competition, and market segmentation in the prescription drug market, International Journal of Industrial Organization, 26(4), 930948.

48. Reiffen, D., and M. R. Ward (2005): Generic drug industry dynamics, Review of Economics and Statistics, 87(1), 3749.

49. Scherer, F. M. (1993): Pricing, prots, and technological progress in the pharmaceutical industry, The Journal of Economic Perspectives, 7(3), 97115.
    Paper not yet in RePEc: Add citation now
    
50. Schwabe, Ulrich and Paffrath, D. (2011): Arzneiverordnungs-Report 2011: Aktuelle Daten, Kosten, Trends und Kommentare. Springer-Verlag.
    Paper not yet in RePEc: Add citation now
    
51. Scott Morton, F., and M. Kyle (2012): Markets for pharmaceutical products, Handbook of Health Economics, 2, 763823.
    Paper not yet in RePEc: Add citation now
    

52. Sorensen, A. T. (2000): Equilibrium price dispersion in retail markets for prescription drugs, Journal of Political Economy, 108(4), 833850.

53. Stock, J. H., J. H. Wright, and M. Yogo (2002): A survey of weak instruments and weak identication in Generalized Method of Moments, Journal of Business and Economic Statistics, 20(4), 518529.

54. Wang, Y. R., and M. V. Pauly (2005): Spillover eects of restrictive drug formularies on physician prescribing behavior: Evidence from Medicaid, Journal of Economics and Management Strategy, 14(3), 755773.

55. Wiggins, S. N., and R. Maness (2004): Price competition in pharmaceuticals: The case of anti-infectives, Economic Inquiry, 42(2), 247263.

56. Ziebarth, N. R. (2010): Estimating price elasticities of convalescent care programmes, The Economic Journal, 120(545), 816844.

1. More cost‐sharing, less cost? Evidence on reference price drugs. (2023). Herr, Annika ; Stuhmeier, Torben ; Wenzel, Tobias.
   In: Health Economics.
   RePEc:wly:hlthec:v:32:y:2023:i:2:p:413-435.

   Full description at Econpapers || Download paper

2. Overcoming inefficiencies in the development of personalized medicine. (2021). Heese, Sebastian H ; Wuttke, David A ; Lutkemeyer, Daniel.
   In: European Journal of Operational Research.
   RePEc:eee:ejores:v:290:y:2021:i:1:p:278-296.

   Full description at Econpapers || Download paper

3. Disentangling moral hazard and adverse selection in private health insurance. (2021). Powell, David ; Goldman, Dana.
   In: Journal of Econometrics.
   RePEc:eee:econom:v:222:y:2021:i:1:p:141-160.

   Full description at Econpapers || Download paper

4. Does prescribing appropriateness reduce health expenditures? Main effects and unintended outcomes.. (2021). Vigani, Daria ; Lucifora, Claudio ; Russo, Antonio.
   In: DISCE - Working Papers del Dipartimento di Economia e Finanza.
   RePEc:ctc:serie1:def103.

   Full description at Econpapers || Download paper

5. On the design of equity-oriented pharmaceutical copayments. (2020). González, Paula ; Gonzalez, Paula.
   In: SERIEs: Journal of the Spanish Economic Association.
   RePEc:spr:series:v:11:y:2020:i:2:d:10.1007_s13209-019-00207-y.

   Full description at Econpapers || Download paper

6. Free GP care and psychological health: Quasi-experimental evidence from Ireland. (2020). Nolan, Anne ; Ma, Yuanyuan ; Smith, James P.
   In: Journal of Health Economics.
   RePEc:eee:jhecon:v:72:y:2020:i:c:s0167629619310999.

   Full description at Econpapers || Download paper

7. Does Free Healthcare Affect Childrens Healthcare Use and Outcomes?. (2019). Noguchi, Haruko ; Kang, Cheolmin ; Kawamura, Akira.
   In: Working Papers.
   RePEc:wap:wpaper:1914.

   Full description at Econpapers || Download paper

8. Effects of primary care cost-sharing among young adults: varying impact across income groups and gender. (2019). Svensson, Mikael ; Jakobsson, Niklas ; Johansson, Naimi.
   In: The European Journal of Health Economics.
   RePEc:spr:eujhec:v:20:y:2019:i:8:d:10.1007_s10198-019-01095-6.

   Full description at Econpapers || Download paper

9. Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review. (2019). Boes, Stefan ; Wettstein, Dominik J.
   In: Applied Health Economics and Health Policy.
   RePEc:spr:aphecp:v:17:y:2019:i:2:d:10.1007_s40258-018-0437-z.

   Full description at Econpapers || Download paper

10. Cost-sharing design matters: A comparison of the rebate and deductible in healthcare. (2019). Douven, Rudy ; Remmerswaal, Minke ; Bijlsma, Michiel ; Boone, Jan.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:170:y:2019:i:c:p:83-97.

    Full description at Econpapers || Download paper

11. Free for Children? Patient Cost-sharing and Healthcare Utilization. (2018). Shigeoka, Hitoshi ; Iizuka, Toshiaki.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25306.

    Full description at Econpapers || Download paper

12. Patient cost-sharing, socioeconomic status, and childrens health care utilization. (2018). Nilsson, Anton ; Paul, Alexander.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:59:y:2018:i:c:p:109-124.

    Full description at Econpapers || Download paper

13. Cost-Sharing Design Matters : A Comparison of the Rebate and Deductible in Healthcare. (2017). Remmerswaal, Minke ; Bijlsma, Michiel ; Boone, Jan ; Douven, R. C. M. H., .
    In: Other publications TiSEM.
    RePEc:tiu:tiutis:67163c04-3d3b-499c-882c-d68b18c48d82.

    Full description at Econpapers || Download paper

14. Cost-Sharing Design Matters : A Comparison of the Rebate and Deductible in Healthcare. (2017). Remmerswaal, Minke ; Bijlsma, Michiel ; Boone, Jan ; Douven, R. C. M. H., .
    In: Other publications TiSEM.
    RePEc:tiu:tiutis:624251d4-89fb-4c0b-8dd1-f0d3d949e591.

    Full description at Econpapers || Download paper

15. Cost-Sharing Design Matters : A Comparison of the Rebate and Deductible in Healthcare. (2017). boone, jan ; Remmerswaal, Minke ; Bijlsma, Michiel ; Douven, R. C. M. H., .
    In: Discussion Paper.
    RePEc:tiu:tiutil:67163c04-3d3b-499c-882c-d68b18c48d82.

    Full description at Econpapers || Download paper

16. Cost-Sharing Design Matters : A Comparison of the Rebate and Deductible in Healthcare. (2017). boone, jan ; Remmerswaal, Minke ; Bijlsma, Michiel ; Douven, R. C. M. H., .
    In: Discussion Paper.
    RePEc:tiu:tiucen:624251d4-89fb-4c0b-8dd1-f0d3d949e591.

    Full description at Econpapers || Download paper

17. A method to simulate incentives for cost containment under various cost sharing designs: an application to a first-euro deductible and a doughnut hole. (2017). Kleef, R C ; R. C. J. A. Vliet, ; Cattel, D.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:18:y:2017:i:8:d:10.1007_s10198-016-0843-9.

    Full description at Econpapers || Download paper

18. The Impacts of Persistent Behaviour and Cost-Sharing Policy on Demand for Outpatient Visits by the Elderly: Evidence from Taiwan’s National Health Insurance. (2017). Tsai, Ying Che ; Tien, Joseph J ; Yang, Chung Jen .
    In: The Geneva Papers on Risk and Insurance - Issues and Practice.
    RePEc:pal:gpprii:v:42:y:2017:i:1:d:10.1057_s41288-016-0022-3.

    Full description at Econpapers || Download paper

19. The Impact of Increased Cost-Sharing on Utilization of Low Value Services: Evidence from the State of Oregon. (2017). Maclean, Johanna ; Volpp, Kevin G ; Gruber, Jonathan ; Wilkinson, Eric ; Wright, Bill.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp10477.

    Full description at Econpapers || Download paper

20. THE EFFECT OF PATIENT COST SHARING ON HEALTH CARE UTILIZATION AMONG LOW-INCOME CHILDREN. (2017). Takaku, Reo.
    In: Hitotsubashi Journal of Economics.
    RePEc:hit:hitjec:v:58:y:2017:i:1:p:69-88.

    Full description at Econpapers || Download paper

21. Cost-Sharing Design Matters: A Comparison of the Rebate and Deductible in Healthcare. (2017). Douven, Rudy ; Remmerswaal, Minke ; Bijlsma, Michiel ; Boone, Jan.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:12507.

    Full description at Econpapers || Download paper

22. Cost-Sharing Design Matters: A Comparison of the Rebate and Deductible in Healthcare. (2017). Douven, Rudy ; Remmerswaal, Minke ; Bijlsma, Michiel ; Boone, Jan.
    In: CPB Discussion Paper.
    RePEc:cpb:discus:367.

    Full description at Econpapers || Download paper

23. THE EFFECT OF INSURANCE COVERAGE ON PREVENTIVE CARE. (2017). Cabral, Marika ; Cullen, Mark R.
    In: Economic Inquiry.
    RePEc:bla:ecinqu:v:55:y:2017:i:3:p:1452-1467.

    Full description at Econpapers || Download paper

24. Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets. (2016). Suppliet, Moritz ; Herr, Annika.
    In: Other publications TiSEM.
    RePEc:tiu:tiutis:6430293b-fde9-4f91-ab35-3fc61de7c0f4.

    Full description at Econpapers || Download paper

25. Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets. (2016). Suppliet, Moritz ; Herr, Annika.
    In: Other publications TiSEM.
    RePEc:tiu:tiutis:4d692f0e-8577-4392-b413-269be650c250.

    Full description at Econpapers || Download paper

26. Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets. (2016). Suppliet, Moritz ; Herr, Annika.
    In: Discussion Paper.
    RePEc:tiu:tiutil:6430293b-fde9-4f91-ab35-3fc61de7c0f4.

    Full description at Econpapers || Download paper

27. Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets. (2016). Suppliet, Moritz ; Herr, Annika.
    In: Discussion Paper.
    RePEc:tiu:tiucen:4d692f0e-8577-4392-b413-269be650c250.

    Full description at Econpapers || Download paper

28. The Impact of Increased Cost-sharing on Utilization of Low Value Services: Evidence from the State of Oregon. (2016). Maclean, Johanna ; Gruber, Jonathan ; Volpp, Kevin ; Wilkinson, Eric S ; Wright, Bill J.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:22875.

    Full description at Econpapers || Download paper

29. Effects of reduced cost-sharing on childrens health: Evidence from Japan. (2016). Takaku, Reo.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:151:y:2016:i:c:p:46-55.

    Full description at Econpapers || Download paper

30. Growth and welfare effects of health care in knowledge-based economies. (2016). Prettner, Klaus ; Kuhn, Michael.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:46:y:2016:i:c:p:100-119.

    Full description at Econpapers || Download paper

31. Patient cost sharing and medical expenditures for the Elderly. (2016). Iizuka, Toshiaki ; Mizuoka, Sou ; Yamamoto, Shunsuke ; Fukushima, Kazuya .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:45:y:2016:i:c:p:115-130.

    Full description at Econpapers || Download paper

32. Using artefactual field and lab experiments to investigate how fee-for-service and capitation affect medical service provision. (2016). Wiesen, Daniel ; Hennig-Schmidt, Heike ; Kairies-Schwarz, Nadja ; Brosig-Koch, Jeannette.
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:131:y:2016:i:pb:p:17-23.

    Full description at Econpapers || Download paper

33. The incidence of high medical expenses by health status in seven developed countries. (2016). Baird, Katherine Elizabeth .
    In: Health Policy.
    RePEc:eee:hepoli:v:120:y:2016:i:1:p:26-34.

    Full description at Econpapers || Download paper

34. Golden Aging. (2015). Bussolo, Maurizio ; Koettl, Johannes ; Sinnott, Emily .
    In: World Bank Publications - Books.
    RePEc:wbk:wbpubs:22018.

    Full description at Econpapers || Download paper

35. Competitive pricing within pharmaceutical classes: evidence on “follow-on” drugs in Germany 1993–2008. (2015). FRENZEL, Alexander ; Mueller, Michael.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:16:y:2015:i:1:p:73-82.

    Full description at Econpapers || Download paper

36. Impact of Chinas Urban Employee Basic Medical Insurance on Health Care Expenditure and Health Outcomes. (2015). Gan, Li ; Huang, Feng.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:20873.

    Full description at Econpapers || Download paper

37. On the relationship between the negotiated prices of pharmaceuticals and the patients co-payment. (2015). Jelovac, Izabela.
    In: Economics Bulletin.
    RePEc:ebl:ecbull:eb-13-00355.

    Full description at Econpapers || Download paper

38. Medical Care Expenditure Indexes for the US, 1980-2006. (2015). HIGHFILL, TINA ; Aizcorbe, Ana.
    In: BEA Working Papers.
    RePEc:bea:wpaper:0121.

    Full description at Econpapers || Download paper

39. Reference pricing and cost-sharing: Theory and evidence on German off-patent drugs. (2014). Wenzel, Tobias ; Stuehmeier, Torben ; Herr, Annika ; Stuhmeier, Torben.
    In: VfS Annual Conference 2014 (Hamburg): Evidence-based Economic Policy.
    RePEc:zbw:vfsc14:100556.

    Full description at Econpapers || Download paper

40. The Effect of Copayments on Childrens and Adolescents Demand for Medical Care. (2014). Nilsson, Anton ; Paul, Alexander.
    In: VfS Annual Conference 2014 (Hamburg): Evidence-based Economic Policy.
    RePEc:zbw:vfsc14:100403.

    Full description at Econpapers || Download paper

41. TURKEY ON THE WAY OF UNIVERSAL HEALTH COVERAGE THROUGH THE HEALTH TRANSFORMATION PROGRAM (2003-13). (2014). Aran, Meltem ; Tatar, Mehtap ; Bump, Jesse ; Rokx, Claudia ; Celik, Yusuf ; Sparkes, Susan.
    In: Health, Nutrition and Population (HNP) Discussion Paper Series.
    RePEc:wbk:hnpdps:93172.

    Full description at Econpapers || Download paper

42. Turkey on the Way of Universal Health Coverage Through the Health Transformation Program (2003-2013). (2014). Aran, Meltem ; Rokx, Claudia.
    In: Health, Nutrition and Population (HNP) Discussion Paper Series.
    RePEc:wbk:hnpdps:91326.

    Full description at Econpapers || Download paper

43. The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland. (2014). Saastamoinen, Leena ; Martikainen, Jaana ; Mikkola, Hennamari ; Koskinen, Hanna ; Ahola, Elina .
    In: Health Economics Review.
    RePEc:spr:hecrev:v:4:y:2014:i:1:p:1-10:10.1186/s13561-014-0009-3.

    Full description at Econpapers || Download paper

44. Assessing the effectiveness of health care cost containment measures: evidence from the market for rehabilitation care. (2014). Ziebarth, Nicolas.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:14:y:2014:i:1:p:41-67.

    Full description at Econpapers || Download paper

45. Using artefactual field and lab experiments to investigate how fee-for-service and capitation affect medical service provision. (2014). Wiesen, Daniel ; Hennig-Schmidt, Heike ; Kairies-Schwarz, Nadja ; Brosig-Koch, Jeannette.
    In: HERO Online Working Paper Series.
    RePEc:hhs:oslohe:2014_003.

    Full description at Econpapers || Download paper

46. The impact of patient cost-sharing on low-income populations: Evidence from Massachusetts. (2014). McKnight, Robin ; Gruber, Jonathan ; Chandra, Amitabh.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:33:y:2014:i:c:p:57-66.

    Full description at Econpapers || Download paper

47. MEDICARE FOR ALL: A PUBLIC FINANCE ANALYSIS. (2014). Seidman, Laurence.
    In: Working Papers.
    RePEc:dlw:wpaper:14-02..

    Full description at Econpapers || Download paper

48. The Changing Role of Government in Financing Health Care: An International Perspective. (2014). Stabile, Mark ; Thomson, Sarah.
    In: Journal of Economic Literature.
    RePEc:aea:jeclit:v:52:y:2014:i:2:p:480-518.

    Full description at Econpapers || Download paper

49. The impact of generic reference pricing in Italy, a decade on. (2013). Ghislandi, Simone ; Armeni, Patrizio ; Jommi, Claudio.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:14:y:2013:i:6:p:959-969.

    Full description at Econpapers || Download paper

50. The Effect of U.S. Health Insurance Expansions on Medical Innovation. (2013). Clemens, Jeffrey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:19761.

    Full description at Econpapers || Download paper

51. Is This Time Different? The Slowdown in Healthcare Spending. (2013). Skinner, Jonathan ; Chandra, Amitabh ; Holmes, Jonathan.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:19700.

    Full description at Econpapers || Download paper

52. Medicare for All. (2013). Seidman, Laurence.
    In: Challenge.
    RePEc:mes:challe:v:56:y:2013:i:1:p:88-115.

    Full description at Econpapers || Download paper

53. Trends in cost sharing among selected high income countries—2000–2010. (2013). Hossein, Zare ; Gerard, Anderson .
    In: Health Policy.
    RePEc:eee:hepoli:v:112:y:2013:i:1:p:35-44.

    Full description at Econpapers || Download paper

54. Integrating Patient Incentives with Episode-Based Payment. (2013). Hirth Richard A., ; Helmchen Lorens A., ; Encinosa William E., ; Chernew Michael E., .
    In: Forum for Health Economics & Policy.
    RePEc:bpj:fhecpo:v:16:y:2013:i:1:p:14:n:1.

    Full description at Econpapers || Download paper

55. Is This Time Different? The Slowdown in Healthcare Spending. (2013). Holmes, Jonathan ; Chandra, Amitabh.
    In: Brookings Papers on Economic Activity.
    RePEc:bin:bpeajo:v:47:y:2013:i:2013-02:p:261-323.

    Full description at Econpapers || Download paper

56. Rationalisierung und Wettbewerb im Arzneimittelmarkt. (2012). Herr, Annika.
    In: DICE Ordnungspolitische Perspektiven.
    RePEc:zbw:diceop:31.

    Full description at Econpapers || Download paper

57. Co-Payment Exemptions and Reference Prices: an Empirical Study of Pharmaceutical Prices in Germany. (2011). Suppliet, Moritz ; Herr, Annika.
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:11/18.

    Full description at Econpapers || Download paper

58. Free Medicines thanks to Retirement: Moral Hazard and Hospitalization Offsets in an NHS. (2011). Garcia-Gomez, Pilar ; Puig-Junoy, Jaume ; Casado-Marin, David .
    In: Tinbergen Institute Discussion Papers.
    RePEc:tin:wpaper:20110108.

    Full description at Econpapers || Download paper

59. Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

    Full description at Econpapers || Download paper

60. Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort. (2011). Reuter, Stefan ; Kollan, Christian ; Hamouda, Osamah ; Fritzsche, Carlos ; Stoll, Matthias ; Bartmeyer, Barbara ; Hoeper, Kirsten ; Clinsurv, And The ; Rockstroh, Jurgen ; Plettenberg, Andreas ; Bogner, Johannes ; van Lunzen, Jan ; Horst, Heinz-August ; Stellbrink, Hans-Jurgen ; Faetkenheuer, Gerd ; Bergmann, Frank.
    In: PLOS ONE.
    RePEc:plo:pone00:0023946.

    Full description at Econpapers || Download paper

61. Has the European union achieved a single pharmaceutical market?. (2011). Picone, Gabriel ; DeSimone, Jeffrey ; Timur, Aysegul.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:11:y:2011:i:4:p:223-244.

    Full description at Econpapers || Download paper

62. Aspirin, angioplasty and proton beam therapy: the economics of smarter health-care spending. (2011). Chandra, Amitabh ; Baicker, Katherine.
    In: Proceedings - Economic Policy Symposium - Jackson Hole.
    RePEc:fip:fedkpr:y:2011:p:197-235.

    Full description at Econpapers || Download paper

63. Too much cocited documents. This list is not complete

Report date: 2025-09-30 20:42:17 || Missing content? Let us know